Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
LAVA Therapeutics NV - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
LVTX
Nasdaq
8731
https://www.lavatherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for LAVA Therapeutics NV
LAVA Therapeutics Full Year 2023 Earnings: Revenues Disappoint
- Mar 21st, 2024 10:19 am
LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results
- Mar 20th, 2024 11:00 am
LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223)
- Mar 5th, 2024 12:30 pm
LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®
- Jan 25th, 2024 12:00 pm
Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
- Nov 16th, 2023 12:00 pm
LAVA Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
- Sep 6th, 2023 11:11 am
LAVA Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
- Aug 22nd, 2023 11:00 am
LAVA Therapeutics to Participate in the H.C. Wainwright Immune Cell Engager Virtual Conference
- Aug 14th, 2023 11:00 am
LAVA Therapeutics Provides Updates on Clinical Programs and Extends the Cash Runway
- Jun 14th, 2023 1:00 pm
LAVA Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
- Jun 8th, 2023 11:00 am
LAVA Therapeutics Announces Selection by Janssen of Lead Gamma-Delta T-Cell Engager Bispecific Antibody to Move Toward Clinical Development
- Jun 1st, 2023 8:20 pm
LAVA Therapeutics to Participate in the Jefferies Healthcare Conference
- Jun 1st, 2023 12:09 pm
LAVA Announces Annual Meeting of Shareholders
- May 30th, 2023 9:28 pm
Scroll